Worsening or improving hypoalbuminemia during continuous renal replacement therapy is predictive of patient outcome: a single-center retrospective study

[1]  K. Kashani,et al.  Impact of hypoalbuminemia on mortality in critically ill patients requiring continuous renal replacement therapy. , 2021, Journal of critical care.

[2]  Jingye Pan,et al.  Reduced serum albumin as a risk factor for poor prognosis in critically ill patients receiving renal replacement therapy , 2021, BMC Nephrology.

[3]  Hai Wang,et al.  Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy , 2021, Frontiers in Nutrition.

[4]  Y. Kim,et al.  Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy , 2020, Kidney research and clinical practice.

[5]  P. Schuetz,et al.  Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: A prospective study. , 2019, The American journal of medicine.

[6]  U. Keller.  Nutritional Laboratory Markers in Malnutrition , 2019, Journal of clinical medicine.

[7]  Miyeun Han,et al.  Long-term outcomes in acute kidney injury patients who underwent continuous renal replacement therapy: a single-center experience , 2018, Clinical and Experimental Nephrology.

[8]  Miyeun Han,et al.  The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience , 2017, BMC Nephrology.

[9]  Dong Won Lee,et al.  Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy , 2017, PloS one.

[10]  A. Gossum,et al.  ESPEN guidelines on definitions and terminology of clinical nutrition. , 2017, Clinical nutrition.

[11]  J. Kellum,et al.  Patient Selection and Timing of Continuous Renal Replacement Therapy , 2016, Blood Purification.

[12]  Dong Won Lee,et al.  Use of Multifrequency Bioimpedance Analysis in Male Patients with Acute Kidney Injury Who Are Undergoing Continuous Veno-Venous Hemodiafiltration , 2015, PloS one.

[13]  A. Gossum,et al.  Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. , 2015, Clinical nutrition.

[14]  D. Cuadras,et al.  Serum albumin and health in older people: Review and meta analysis. , 2015, Maturitas.

[15]  R. Jalan,et al.  Albumin in chronic liver disease: structure, functions and therapeutic implications , 2015, Hepatology International.

[16]  G. Martin,et al.  Albumin administration in the acutely ill: what is new and where next? , 2014, Critical Care.

[17]  Marcelo Park,et al.  C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients , 2013, PloS one.

[18]  D. Gupta,et al.  Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature , 2010, Nutrition journal.

[19]  R. Bellomo,et al.  Fluid balance and acute kidney injury , 2010, Nature Reviews Nephrology.

[20]  Jonathan Himmelfarb,et al.  Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. , 2009, Kidney international.

[21]  T. Stewart,et al.  Albumin in critical care: SAFE, but worth its salt? , 2004, Critical care.

[22]  G. Park,et al.  The role of albumin in critical illness. , 2000, British journal of anaesthesia.

[23]  R. Kishen,et al.  The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit , 1996, Anaesthesia.

[24]  T. Standiford,et al.  Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. , 1995, Journal of immunology.

[25]  W. Martin,et al.  Endotoxin‐induced arterial endothelial barrier dysfunction assessed by an in vitro model , 1993, British journal of pharmacology.

[26]  D. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1992, Nature.

[27]  R. Bone,et al.  The pathogenesis of sepsis. , 1991, Annals of internal medicine.

[28]  P. Heinrich,et al.  Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6 , 1990, Hepatology.

[29]  F. Ognibene,et al.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.

[30]  D. Brenner,et al.  Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. , 1990, The Journal of clinical investigation.

[31]  K. Calman,et al.  INCREASED VASCULAR PERMEABILITY: A MAJOR CAUSE OF HYPOALBUMINAEMIA IN DISEASE AND INJURY , 1985, The Lancet.

[32]  G. Howlett,et al.  The acute phase response of plasma protein synthesis during experimental inflammation. , 1982, The Journal of biological chemistry.

[33]  J. Henzen.  Publisher's note , 1979, Brain Research.